Correlation Between Rxsight and Cytek Biosciences

Can any of the company-specific risk be diversified away by investing in both Rxsight and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rxsight and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rxsight and Cytek Biosciences, you can compare the effects of market volatilities on Rxsight and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rxsight with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rxsight and Cytek Biosciences.

Diversification Opportunities for Rxsight and Cytek Biosciences

0.85

Correlation Coefficient

Rxsight  Cytek Biosciences

Very poor diversification

The 3 months correlation between Rxsight and Cytek is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Rxsight and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and Rxsight is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rxsight are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of Rxsight i.e., Rxsight and Cytek Biosciences go up and down completely randomly.

Pair Corralation between Rxsight and Cytek Biosciences

Given the investment horizon of 90 days Rxsight is expected to generate 1.49 times more return on investment than Cytek Biosciences. However, Rxsight is 1.49 times more volatile than Cytek Biosciences. It trades about -0.12 of its potential returns per unit of risk. Cytek Biosciences is currently generating about -0.24 per unit of risk. If you would invest  3,073  in Rxsight on February 19, 2025 and sell it today you would lose (1,441) from holding Rxsight or give up 46.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Rxsight  vs.  Cytek Biosciences

Rxsight

Risk-Adjusted Performance

Very Weak

Over the last 90 days Rxsight has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in June 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cytek Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cytek Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking signals remain somewhat strong which may send shares a bit higher in June 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Rxsight and Cytek Biosciences

The main advantage of trading using opposite Rxsight and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rxsight position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.

The idea behind Rxsight and Cytek Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.